PMV Pharmaceuticals

About:

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Twitter/X: pmvpharma

Top Investors: Wellington Management, RA Capital Management, OrbiMed, Euclidean Capital, Boxer Capital

Description:

PMV Pharma is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus.

Total Funding Amount:

$236M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Redwood City, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)pmvpharma.com

Founders:

Arnold Levine, David Mack, Thomas Shenk

Number of Employees:

51-100

Last Funding Date:

2020-08-03

IPO Status:

Public

Industries: